BIOADAPTIVES, INC. logo

BIOADAPTIVES, INC.

BDPT
Last price US$0.0012
Market cap US$10800.0
12M price change N/A
Loading the 12-month Mave Thesis and 1-month news signal

Dashboard Funda..tals Prediction Screener Map

BIOADAPTIVES, INC. Overview

Industry: Packaged Foods

Sector: Consumer Defensive

BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada. BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute fo Read More

Mavefund brings filings, fundamentals, valuation, price history and news for BIOADAPTIVES, INC. into one research view. The sections below show what strengthens or weakens the research case.

Score

Reported Results

What the company reported, with filing details kept small.

Filed May 15, 2026

Quarterly result summary

Latest company-filed earnings material is available for source review.

What changed

  • Review the SEC source filing for the full reported results and management commentary.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

SEC filing Open filing

Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

Other recent earnings materials

Prediction-grade evidence

Recent News

Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

Earnings Per Share

Score 3.00/5
BIOADAPTIVES, INC. boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Hershey Co Procter & Gamble Company Grand Canyon Education Inc
In Packaged Foods industry , General Mills Inc , Ingredion Inc , FLOWERS FOODS INC are companies with high ratings.

Return on Equity

Score 3.85/5
BIOADAPTIVES, INC. stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Hershey Co Procter & Gamble Company Grand Canyon Education Inc
BIOADAPTIVES... BDPT US$10800
Hershey Co HSY US$36.9b
Procter & Ga... PG US$343.4b
Grand Canyon... LOPE US$4.0b

Net Margin

Score -0.94/5
BIOADAPTIVES, INC. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Hershey Co Procter & Gamble Company Grand Canyon Education Inc
BIOADAPTIVES... BDPT US$10800
Hershey Co HSY US$36.9b
Procter & Ga... PG US$343.4b
Grand Canyon... LOPE US$4.0b

Share Buyback

In Packaged Foods industry , General Mills Inc , Ingredion Inc , FLOWERS FOODS INC are companies with high ratings.

Leverage

Score 2.99/5
BIOADAPTIVES, INC. attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Hershey Co Procter & Gamble Company Grand Canyon Education Inc , also exhibit high scores.
BIOADAPTIVES... BDPT US$10800
Hershey Co HSY US$36.9b
Procter & Ga... PG US$343.4b
Grand Canyon... LOPE US$4.0b

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

Verified SEC statements load when this section enters view.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

BIOADAPTIVES, INC. logo

BIOADAPTIVES, INC.

US$0.0012

US$10800.0

-25.00%

N/A